Susan Hubbard | Executive Vice President of Public Affairs and Investor Relations |
Michael Morrissey | President and Chief Executive Officer |
Gisela Schwab | President, Product Development and Medical Affairs and Chief Medical Officer |
Peter Lamb | Executive Vice President, Scientific Strategy and Chief Scientific Officer |
Christopher Senner | Executive Vice President and Chief Financial Officer |
P.J. Haley | Senior Vice President Commercial |
Eric Schmidt | Cowen & Company |
Andy Hsieh | William Blair & Company, L.L.C. |
Peter Lawson | SunTrust Robinson Humphrey |
Kennen MacKay | RBC Capital Markets |
Stephen Willey | Stifel, Nicolaus & Company |
Michael Schmidt | Leerink Partners LLC |
Andrew Peters | Deutsche Bank |
Good day, ladies and gentlemen, and welcome to the Exelixis’ Fourth Quarter and Full-Year 2017 Financial Results Conference Call. My name is Sabrina, and I'll be your operator for today.
As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations.